Benign prostatic hyperplasia laboratory findings

Jump to navigation Jump to search

Benign prostatic hyperplasia Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Benign Prostatic Hyperplasia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Benign prostatic hyperplasia laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Benign prostatic hyperplasia laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Benign prostatic hyperplasia laboratory findings

CDC on Benign prostatic hyperplasia laboratory findings

Benign prostatic hyperplasia laboratory findings in the news

Blogs on Benign prostatic hyperplasia laboratory findings

Directions to Hospitals Treating Benign prostatic hyperplasia

Risk calculators and risk factors for Benign prostatic hyperplasia laboratory findings

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Steven C. Campbell, M.D., Ph.D.

Overview

Often, blood tests are performed to rule out prostatic malignancy: elevated prostate specific antigen (PSA) levels needs further investigations such as reinterpretation of PSA results, in terms of PSA density and PSA free percentage, rectal examination and transrectal ultrasonography. These combined measures can provide early cancer detection.

References

Template:WH Template:WS